Oldenburg Catherine E, Bärnighausen Till, Tanser Frank, Iwuji Collins C, De Gruttola Victor, Seage George R, Mimiaga Matthew J, Mayer Kenneth H, Pillay Deenan, Harling Guy
Department of Epidemiology.
Department of Global Health and Population Africa Centre for Population Health, Mtubatuba.
Clin Infect Dis. 2016 Aug 15;63(4):548-54. doi: 10.1093/cid/ciw335. Epub 2016 May 20.
Antiretroviral therapy (ART) was highly efficacious in preventing human immunodeficiency virus (HIV) transmission in stable serodiscordant couples in the HPTN-052 study, a resource-intensive randomized controlled trial with near-perfect ART adherence and mutual HIV status disclosure among all participating couples. However, minimal evidence exists of the effectiveness of ART in preventing HIV acquisition in stable serodiscordant couples in "real-life" population-based settings in hyperendemic communities of sub-Saharan Africa, where health systems are typically resource-poor and overburdened, adherence to ART is often low, and partners commonly do not disclose their HIV status to each other.
Data arose from a population-based open cohort in KwaZulu-Natal, South Africa. A total of 17 016 HIV-uninfected individuals present between January 2005 and December 2013 were included. Interval-censored time-updated proportional hazards regression was used to assess how the ART status affected HIV transmission risk in stable serodiscordant relationships.
We observed 1619 HIV seroconversions in 17 016 individuals, over 60 349 person-years follow-up time. During the follow-up period, 1846 individuals had an HIV-uninfected and 196 had an HIV-infected stable partner HIV incidence was 3.8/100 person-years (PY) among individuals with an HIV-infected partner (95% confidence interval [CI], 2.3-5.6), 1.4/100 PY (.4-3.5) among those with HIV-infected partners receiving ART, and 5.6/100 PY (3.5-8.4) among those with HIV-infected partners not receiving ART. Use of ART was associated with a 77% decrease in HIV acquisition risk among serodiscordant couples (adjusted hazard ratio, 0.23; 95% CI, .07-.80).
ART initiation was associated with a very large reduction in HIV acquisition in serodiscordant couples in rural KwaZulu-Natal. However, this "real-life" effect was substantially lower than the effect observed in the HPTN-052 trial. To eliminate HIV transmission in serodiscordant couples, additional prevention interventions are probably needed.
在HPTN - 052研究中,抗逆转录病毒疗法(ART)在预防稳定的血清学不一致夫妻间的人类免疫缺陷病毒(HIV)传播方面非常有效,这是一项资源密集型随机对照试验,所有参与夫妻对抗逆转录病毒疗法的依从性近乎完美,且双方都知晓彼此的HIV感染状况。然而,在撒哈拉以南非洲高流行社区基于“现实生活”人群的环境中,关于抗逆转录病毒疗法在预防稳定的血清学不一致夫妻感染HIV有效性的证据极少,在这些地区,卫生系统通常资源匮乏且负担过重,抗逆转录病毒疗法的依从性往往较低,伴侣之间通常也不会相互透露自己的HIV感染状况。
数据来源于南非夸祖鲁 - 纳塔尔省一个基于人群的开放队列。纳入了2005年1月至2013年12月期间出现的总共17016名未感染HIV的个体。采用区间截尾时间更新比例风险回归来评估抗逆转录病毒疗法状态如何影响稳定的血清学不一致关系中的HIV传播风险。
在17016名个体超过60349人年的随访时间里,我们观察到1619例HIV血清转化。在随访期间,1846名个体有未感染HIV的稳定伴侣,196名个体有感染HIV的稳定伴侣。在有感染HIV伴侣的个体中,HIV发病率为3.8/100人年(95%置信区间[CI],2.3 - 5.6);在其感染HIV的伴侣接受抗逆转录病毒疗法的个体中,发病率为1.4/100人年(0.4 - 3.5);在其感染HIV的伴侣未接受抗逆转录病毒疗法 的个体中,发病率为5.6/100人年(3.5 - 8.4)。在血清学不一致的夫妻中,使用抗逆转录病毒疗法使感染HIV的风险降低了77%(调整后的风险比,0.23;95%CI,0.07 - 0.80)。
在夸祖鲁 - 纳塔尔省农村地区,启动抗逆转录病毒疗法与血清学不一致夫妻感染HIV的大幅减少相关。然而,这种“现实生活”中的效果远低于在HPTN - 052试验中观察到的效果。为消除血清学不一致夫妻间的HIV传播,可能需要额外的预防干预措施。